SCYNEXIS, Inc. Stock Analysis & AI Score
SCYNEXIS, Inc. (SCYX) has an ST Score of 44.1 (C+), driven by its Financial Strength (A+) and held back by its Momentum (D). Analysts rate it Buy.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Pharmaceuticals |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
SCYNEXIS, Inc. (SCYX) has an ST Score of 44.1 (C+), driven by its Financial Strength (A+) and held back by its Momentum (D). Analysts rate it Buy.
- Strongest
- Financial StrengthA+
- Weakest
- MomentumD
All factor grades
- Financial StrengthA+
- ValuationB
- ProfitabilityC
- GrowthC-
- MomentumD
- Piotroski2/9
Contact
SCYX stock: frequently asked questions
What is SCYX's ST Score?
SCYNEXIS, Inc. (SCYX) has an ST Score of 44.1 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is SCYX a buy, hold, or sell?
Analysts rate SCYX a Buy. Our ST Score grades it C+ (44.1/100). The ST Score is a data-driven signal, not a recommendation.
What are SCYX's factor grades?
Valuation B, Profitability C, Financial Strength A+, Momentum D, Growth C-.
What is SCYX's valuation grade?
SCYNEXIS, Inc. (SCYX) earns a valuation grade of B, measured against Medical - Pharmaceuticals peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is SCYX's growth grade?
SCYNEXIS, Inc. (SCYX) earns a growth grade of C-, measured against Medical - Pharmaceuticals peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is SCYX's profitability grade?
SCYNEXIS, Inc. (SCYX) earns a profitability grade of C, measured against Medical - Pharmaceuticals peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is SCYX's financial strength grade?
SCYNEXIS, Inc. (SCYX) earns a financial strength grade of A+, measured against Medical - Pharmaceuticals peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is SCYX's Piotroski score?
SCYNEXIS, Inc. (SCYX) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.